Antibodies that bind to antigens expressed on the merozoite form of the malaria parasite can inhibit parasite growth by preventing merozoite invasion of red blood cells. Inhibitory antibodies are found in the sera of malaria-immune individuals, however, the specificity of those that are important to this process is not known. In this paper, we have used allelic replacement to construct a Plasmodium falciparum parasite line that expresses the complete COOH-terminal fragment of merozoite surface protein (MSP)-119 from the divergent rodent malaria P. chabaudi. By comparing this transfected line with parental parasites that differ only in MSP-119, we show that antibodies specific for this domain are a major component of the inhibitory response in P. falciparum–immune humans and P. chabaudi–immune mice. In some individual human sera, MSP-119 antibodies dominated the inhibitory activity. The finding that antibodies to a small region of a single protein play a major role in this process has important implications for malaria immunity and is strongly supportive of further understanding and development of MSP-119–based vaccines.
Skip Nav Destination
Article navigation
18 June 2001
Article Contents
Article|
June 18 2001
Antibodies against Merozoite Surface Protein (Msp)-119 Are a Major Component of the Invasion-Inhibitory Response in Individuals Immune to Malaria
Rebecca A. O'Donnell,
Rebecca A. O'Donnell
bThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3050, Australia
Search for other works by this author on:
Tania F. de Koning-Ward,
Tania F. de Koning-Ward
aDepartment of Microbiology & Immunology and the Co-operative Research Centre for Vaccine Technology, University of Melbourne, VIC 3010, Australia
bThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3050, Australia
Search for other works by this author on:
Rachel A. Burt,
Rachel A. Burt
bThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3050, Australia
Search for other works by this author on:
Moses Bockarie,
Moses Bockarie
cPapua New Guinea Institute of Medical Research, Goroka EHP 441 and Madang MAD 511, Papua New Guinea
Search for other works by this author on:
John C. Reeder,
John C. Reeder
cPapua New Guinea Institute of Medical Research, Goroka EHP 441 and Madang MAD 511, Papua New Guinea
Search for other works by this author on:
Alan F. Cowman,
Alan F. Cowman
bThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3050, Australia
Search for other works by this author on:
Brendan S. Crabb
Brendan S. Crabb
aDepartment of Microbiology & Immunology and the Co-operative Research Centre for Vaccine Technology, University of Melbourne, VIC 3010, Australia
bThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3050, Australia
Search for other works by this author on:
Rebecca A. O'Donnell
bThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3050, Australia
Tania F. de Koning-Ward
aDepartment of Microbiology & Immunology and the Co-operative Research Centre for Vaccine Technology, University of Melbourne, VIC 3010, Australia
bThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3050, Australia
Rachel A. Burt
bThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3050, Australia
Moses Bockarie
cPapua New Guinea Institute of Medical Research, Goroka EHP 441 and Madang MAD 511, Papua New Guinea
John C. Reeder
cPapua New Guinea Institute of Medical Research, Goroka EHP 441 and Madang MAD 511, Papua New Guinea
Alan F. Cowman
bThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3050, Australia
Brendan S. Crabb
aDepartment of Microbiology & Immunology and the Co-operative Research Centre for Vaccine Technology, University of Melbourne, VIC 3010, Australia
bThe Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3050, Australia
Abbreviations used in this paper: EGF, epidermal growth factor; GST, glutathione S transferase; HNIS, human nonimmune sera; IFA, immunofluorescence assay; MSP, merozoite surface protein; OD, optical density.
Received:
March 30 2001
Revision Requested:
April 30 2001
Accepted:
May 16 2001
Online ISSN: 1540-9538
Print ISSN: 0022-1007
© 2001 The Rockefeller University Press
2001
The Rockefeller University Press
J Exp Med (2001) 193 (12): 1403–1412.
Article history
Received:
March 30 2001
Revision Requested:
April 30 2001
Accepted:
May 16 2001
Citation
Rebecca A. O'Donnell, Tania F. de Koning-Ward, Rachel A. Burt, Moses Bockarie, John C. Reeder, Alan F. Cowman, Brendan S. Crabb; Antibodies against Merozoite Surface Protein (Msp)-119 Are a Major Component of the Invasion-Inhibitory Response in Individuals Immune to Malaria. J Exp Med 18 June 2001; 193 (12): 1403–1412. doi: https://doi.org/10.1084/jem.193.12.1403
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement